Journal
CELL
Volume 184, Issue 9, Pages 2271-2275Publisher
CELL PRESS
DOI: 10.1016/j.cell.2021.02.022
Keywords
-
Categories
Funding
- National Institutes of Health [P50AI150476, U19AI135990, U19AI135972, R01AI143292, R01AI120694, U01MH115747, U54CA209891, R01AG059751, U54NS100717, P01HL146366, R01AI152161, P01A1063302, R01AI122747]
- Defense Advanced Research Projects Agency (DARPA) [HR0011-19-2-0020, HR001119S0092-FP-FP002]
- UCSF [133122P]
- GSK [133122P]
- Emergent Ventures program at the Mercatus Center of George Mason University
- Roddenberry Foundation
- F. Hoffmann-La Roche
- Vir Biotechnology
- UCB [133122P]
Ask authors/readers for more resources
The scientific world often places more emphasis on individual achievements, but collaboration is crucial especially during times of crisis. Breaking down barriers and fostering global partnerships are essential for tackling key issues such as research on SARS-CoV-2.
The scientific world rewards the individual while often discouraging collaboration. However, times of crisis show us how much more we can accomplish when we work together. Here, we describe our approach to breaking down silos and fostering global collaborations and share the lessons we have learned, especially pertaining to research on SARS-CoV-2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
